Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Clin Cancer Res. 2008 Oct 1;14(19):6343–6349. doi: 10.1158/1078-0432.CCR-08-1198

Table 3.

Odds ratios of SCCHN associated with CASP3 genotypes in the stratified analysis

Stratified
variables
CASP3 (rs4647601:G>T)
P
and trend test
no. of
case/control
no. of
case/control
Adjusted OR
(95% CI)
no. of
case/control
Adjusted OR
(95% CI)
GG GT GT vs. GG TT TT vs. GG
Age
 ≤ 56 150/203 215/228 1.25 (0.93-1.67) 93/82 1.62 (1.02-2.34) 0.052/0.012
 >56 164/162 220/235 0.93 (0.69-1.56) 88/83 1.05 (0.71-1.56) 0.746/0.909
Gender
 Male 245/281 331/364 1.04 (0.82-1.31) 148/121 1.45 (1.07-1.97) 0.062/0.032
 Female 69/84 104/99 1.25 (0.80-1.98) 33/44 0.94 (0.52-1.70) 0.341/0.938
Smoking status
 Never 83/192 116/213 1.27 (0.90-1.80) 55/78 1.61 (1.04-2.48) 0.077/0.028
 Former 104/128 169/177 1.20 (0.86-1.68) 69/57 1.54 (0.99-2.38) 0.197/0.056
 Current 127/45 150/73 0.76 (0.48-1.19) 57/30 0.86 (0.48-1.54) 0.261/0.461
Alcohol use
 Never 76/165 118/205 1.21 (0.85-1.74) 62/78 1.59 (0.95-1.85) 0.044/0.038
 Former 70/56 99/77 0.95 (0.59-1.54) 37/24 1.13 (0.60-2.14) 0.791/0.794
 Current 168/144 218/181 1.07 (0.78-1.46) 82/63 1.32 (0.86-2.00) 0.864/0.228
Tumor site
 Oral cavity 92/365 141/463 1.12 (0.82-1.53) 49/165 1.15 (0.76-1.73) 0.438/0.465
 Pharynx 171/365 228/463 1.04 (0.81-1.33) 99/165 1.28 (0.93-1.76) 0.275/0.161
 Larynx 51/365 66/463 0.96 (0.64-1.47) 49/165 1.36 (0.81-2.30) 0.266/0.330

The result is bolded if the 95% confidence interval does not include 1 or P < 0.05.

*

No. (cases/controls) for each stratum

Adjusted OR, odds ratios were adjusted for all covariates (age, gender, smoking status, and alcohol use), excluding the stratified variable.

P value was from the χ2 test statistics from comparisons of genotype frequencies between cases and controls and P value for the allele trend test obtained from logistic regression analyses.